Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab

PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions
Follicular Lymphoma
Interventions
DRUG

fludarabine

fludarabine 40mg/m2/day orally on Days 1 to 5 of every 35-day cycle

DRUG

rituximab

rituximab 375mg/m2 on Day 1 of every 35-day cycle

DRUG

VELCADE

1.6 mg/m2 intravenously (IV) on Days 1, 8, 15, and 22 of every 35-day cycle

Trial Locations (43)

9007

Kantonsspital St.Gallen Department of Oncology/Hematology, Sankt Gallen

10967

Vivantes Klinikum am Urban, Berlin, BE

11009

Hospital Puerta del Mar, Secretaría de Hematología, 1ª planta, Cadiz

11527

Laiko Hospital - 1st Dept. of Propaedeutic Internal Medicine, Athens

18101

Haemek Medical Center - Hematology Department, Afula

30008

Hospital General Universitario Morales Meseguer, Secretaría de Hematología, 1ª planta, Murcia

30029

CHU Caremeau, Nîmes

31096

Rambam Med.Center - Hematology Institute, Haifa

33076

Institut Bergonie, Bordeaux

37007

Hospital Clinico Universitario Salamanca, Servicio de Hematología, 4º Planta, Salamanca

49100

Rabin Medical Center - Hematology Institute, Petah Tikva

52621

Sheba MC - Hematology Institute, Ramat Gan

55131

Universitaetsklinikum Mainz, Mainz

63000

CHU Hotel Dieu, Clermont-Ferrand

71110

University Hospital of Heraklion- Department of Hematology, Heraklion- Crete

72000

Centre Victor Hugo, Le Mans

75475

Hoptial Saint Louis, Paris Cedex 10, 75

75679

Hopital Cochin, Paris, 75, Cedex 14

78050

Klinikum der Stadt Villinger-Schwenningen, Villingen-Schwenningen

80054

CHU d'Amiens, Amiens

91120

Hadassah University Hospital - Hematology Department, Jerusalem

BY 96049

Klinikum Bamberg, fachbereich 3, Bamberg

BE 12203

Charite, group Benjamin Franklin, Berlin

BE 13585

Hospital Spandau, Berlin

HE 60590

Universitaetsklinikum Frankfurt, Frankfurt

NI 37075

Universitatsklinikum Gottingen, zentrum Innere medicin, Göttingen

NW 50063

Evangelisches Krankenhaus Hamm, Hamm

RP 55743

Klinikum Idar-Oberstein GmbH, Idar-Oberstein

TH 07740

Universitaetsklinikum Jena, Jena

SN 04103

Universitaetsklinikum Leipzig, Leipzig

BW 70376

Robert Bosch Krankenhaus, Stuttgart

RP 54290

Mutterhaus der Borromaeerinnen, Trier

BW 89081

Universitatsklinikum Ulm, Ulm

Unknown

Policlinico di Bari, Bari

Istituto Di Ematologia E Oncologia Medica - L.A. Seragnoli - Policlinico S.Orsola Malpighi, Bologna

Clinica di Ematologia DIMI - A.O. Ospedale S. Martino, Genova

Ospedale Niguarda Ca' Granda, Milan

Azienda Ospedaliera Antonio Cardarelli, Napoli

Ospedale Policlinico San Matteo Irccs, Pavia

A.O.Univ.Pisana-Osp. Santa Chiara, Pisa

Azienda Ospedaliera Santa Maria di Terni, Terni

Divisione di Ematologia Ospedale San Bortolo - Hematology, Vicenza

00161

Università La Sapienza, Dipartimento di Biotecnologie Cellulari ed Ematologia, Via Benevento, 6, Roma

All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Millennium Pharmaceuticals, Inc.

INDUSTRY